Trial intelligence / Profile preview

Prevascar (IL-10) for reduction of scarring in incisional wounds

NCT00984646Phase 2Completed

Sponsor
Renovo
Start
Apr 2005
Primary completion
Nov 2006
Countries
1
01

Overview

A Phase 2 trial of interleukin 10 in cicatrix, sponsored by Renovo. Started Apr 2005; status: completed.

02

Drugs

interleukin 10
03

Conditions

cicatrix

Beyond the preview

Go deeper on NCT00984646.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00984646.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call